Coxsackievirus B4 infection of human fetal thymus cells

被引:38
作者
Brilot, F
Geenen, V
Hober, D
Stoddart, CA
机构
[1] Univ Lille 2, Fac Med, UPRES EA3610, CHRU, F-59037 Lille, France
[2] Univ Lille 2, Fac Med, Serv Virol, CHRU, F-59037 Lille, France
[3] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA
[4] Univ Liege, Inst Pathol, Ctr Immunol, Liege, Belgium
关键词
D O I
10.1128/JVI.78.18.9854-9861.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The infection of human fetal thymus organ cultures (FTOC) with coxsackievirus B4 E2 (CVB4 E2) was investigated. Both positive- and negative-strand viral RNA were detected by real-time quantitative reverse transcription-PCR (RT-PCR) in CVB4 E2-infected FTOC, which supported high yields of virus production (similar to10(6) 50% tissue culture infective doses/ml), and in flow-sorted thymocyte populations for 7 days after inoculation. Cortical CD4(+) CD8(+) thymocytes were found to be the principal targets of infection. Inoculation of human FTOC with CVB4 E2 led to a marked and progressive depletion of immature thymocytes (CD4(+) CD8(+) cells) with no enhancement of Annexin V-positive cells. CVB4 E2 replication caused significant major histocompatibility complex (MHC) class I upregulation on these cells. MHC class I upregulation was correlated with positive- and negative-strand RNA quantitative detection and the release of infectious particles. In addition, chloroquine treatment of FTOC and single-thymocyte suspensions suggested that MHC class I upregulation on thymocytes was the result of direct infection rather than caused by production of soluble factors such as alpha interferon. Thus, CVB4 E2 can infect human fetal thymocytes, which subsequently results in quantitative and qualitative abnormalities of these cells.
引用
收藏
页码:9854 / 9861
页数:8
相关论文
共 50 条
[1]   Two types of death of poliovirus-infected cells: Caspase involvement in the apoptosis but not cytopathic effect [J].
Agol, VI ;
Belov, GA ;
Bienz, K ;
Egger, D ;
Kolesnikova, MS ;
Raikhlin, NT ;
Romanova, LI ;
Smirnova, EA ;
Tolskaya, EA .
VIROLOGY, 1998, 252 (02) :343-353
[2]   CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo [J].
Berkowitz, RD ;
Alexander, S ;
Bare, C ;
Linquist-Stepps, V ;
Bogan, M ;
Moreno, ME ;
Gibson, L ;
Wieder, ED ;
Kosek, J ;
Stoddart, CA ;
McCune, JM .
JOURNAL OF VIROLOGY, 1998, 72 (12) :10108-10117
[3]  
BLUE ML, 1989, J IMMUNOL, V142, P2714
[4]   DEVELOPMENT OF A HUMAN THYMIC ORGAN-CULTURE MODEL FOR THE STUDY OF HIV PATHOGENESIS [J].
BONYHADI, ML ;
SU, LS ;
AUTEN, J ;
MCCUNE, JM ;
KANESHIMA, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (09) :1073-1080
[5]   Persistent infection of human thymic epithelial cells by coxsackievirus B4 [J].
Brilot, F ;
Chehadeh, W ;
Charlet-Renard, C ;
Martens, H ;
Geenen, V ;
Hober, D .
JOURNAL OF VIROLOGY, 2002, 76 (10) :5260-5265
[6]   COXSACKIEVIRUS-B4 INFECTION ALTERS THYMIC, SPLENIC, AND PERIPHERAL LYMPHOCYTE REPERTOIRE PRECEDING ONSET OF HYPERGLYCEMIA IN MICE [J].
CHATTERJEE, NK ;
HOU, J ;
DOCKSTADER, P ;
CHARBONNEAU, T .
JOURNAL OF MEDICAL VIROLOGY, 1992, 38 (02) :124-131
[7]   Increased level of interferon-α in blood of patients with insulin-dependent diabetes mellitus:: Relationship with coxsackievirus B infection [J].
Chehadeh, T ;
Weill, J ;
Vantyghem, MC ;
Alm, G ;
Lefèbvre, J ;
Wattré, P ;
Hober, D .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) :1929-1939
[8]   Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in β cells [J].
Chehadeh, W ;
Kerr-Conte, J ;
Pattou, F ;
Alm, G ;
Lefebvre, J ;
Wattré, P ;
Hober, D .
JOURNAL OF VIROLOGY, 2000, 74 (21) :10153-10164
[9]   Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-α by human peripheral blood mononuclear cells in vitro [J].
Chehadeh, W ;
Bouzidi, A ;
Alm, G ;
Wattré, P ;
Hober, D .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :1899-1907
[10]  
Dahlquist G, 2000, Lakartidningen, V97, P313